| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 1,600 | ₹1,34,400 |
| HNI / NII | 2 | 3,200 | ₹2,68,800 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII / HNI (Total) | — | 6,12,800 (47.46%) | — | ₹514.75 Cr |
| Retail Investors | — | 6,12,800 (47.46%) | — | ₹514.75 Cr |
| Total ** | — | 12,91,200 (100.00%) | — | ₹10,846.08 Cr |
| Market Maker * | — | 65,600 (5.08%) | — | ₹5.51 Cr |
| Metric | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue | 563.58 | 2467.05 | 2690.99 |
| PAT | 75.08 | 204.31 | 77.71 |
| EBITDA | — | — | — |
| Net Worth | 386.60 | 311.52 | 107.20 |
| Total Assets | 1706.28 | 1671.37 | 1301.97 |
| Reserves | 86.60 | 11.52 | 106.20 |
| Borrowings | 347.32 | 214.32 | 323.83 |
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.